Medicis Pharmaceutical Corporation: Premium Company Profile

Publication Date	December 2007
Publisher	Datamonitor
Product Type	Databook
Pages	49
ISBN Number	not applicable
Product Code	DAT09429

Price

£265.00
approximately: $394 | €312

PRINT £265 ($394 | €312)

Order above formats by FAX

Summary

Introduction

Medicis Pharmaceutical focuses on the development and marketing products for the treatment of dermatological, aesthetic and podiatric conditions in the US. It has branded prescription products in a number of therapeutic categories, including acne, fungal infections, psoriasis, rosacea, seborrheic dermatitis, and skin and skin-structure infections.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

The company is involved in developing and marketing dermatological and aesthetics products. Its current products are divided between the dermatological and non-dermatological fields. In the dermatological field it offers products such as Dynacin, Plexion, Solodyn, Triaz and Ziana for the treatment of acne and acne-related dermatological conditions

Medicis generates its revenues from product sales and contracts. The company's total revenues increased at a CAGR of 13% during 2002-2006, from $213 million to $349 million. This represents an absolute growth of +$126 million during the historical period. Product sales were the largest contributor to the total revenue growth.

Medicis' biggest contributor to sales growth out to 2010 will be the product sales (excluding Reloxin) and contract and licensing revenues. Revenues from these streams together are expected to contribute the entire +$368 million of absolute growth during the period 2006-2010.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: Medicis Pharmaceutical - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Medicis Pharmaceutical - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Medicis Pharmaceutical - Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 1: Medicis Pharmaceutical - Key Facts
- Table 2: Medicis Pharmaceutical - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 3: Medicis Pharmaceutical - Key Events Impacting Share Price Performance
- Table 4: Medicis Pharmaceutical - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: Medicis Pharmaceutical - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 6: Medicis Pharmaceutical - Balance Sheet, 2002-2006 ($ Mn)
- Table 7: Medicis Pharmaceutical - Cash Flow, 2002-2006 ($ Mn)
- Table 8: Medicis Pharmaceutical - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 9: Medicis Pharmaceutical - Marketed Products
- Table 10: Medicis Pharmaceutical - in-house Pipeline Products
- Table 11: Medicis Pharmaceutical - Forecast Sales, 2006-2010 ($ Mn)
- Table 12: Medicis Pharmaceutical - Key Competitors
- Table 13: Medicis Pharmaceutical - Key Suppliers
- Table 14: Medicis Pharmaceutical - Key Clients
- Table 15: Medicis Pharmaceutical - Key Shareholders
- Table 16: Medicis Pharmaceutical - SWOT Analysis Summary
- Table 17: Medicis Pharmaceuticals - Value Chain Analysis
- Table 18: Medicis Pharmaceuticals - Scorecard
- Table 19: Medicis Pharmaceutical - Key Employees
- Table 20: Medicis Pharmaceuticals - Financial and Operational Overview